HCM
DGX icon

Hilton Capital Management’s Quest Diagnostics DGX Stock Holding History

Hilton Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.64M Buy
49,211
+1,435
+3% +$279K 0.73% 33
2025
Q4 		$8.29M Buy
47,776
+438
+0.9% +$79.8K 0.62% 37
2025
Q3 		$9.02M Sell
47,338
-3,378
-7% -$599K 0.73% 34
2025
Q2 		$9.11M Sell
50,716
-343
-0.7% -$59.6K 0.73% 36
2025
Q1 		$8.64M Buy
51,059
+821
+2% +$135K 0.73% 36
2024
Q4 		$7.58M Sell
50,238
-6,715
-12% -$1.04M 0.66% 46
2024
Q3 		$8.84M Buy
+56,953
New +$8.51M 0.69% 43

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Hilton Capital Management's DGX Position: Q1 2026 in Review

Hilton Capital Management increased its Quest Diagnostics (DGX) stake by 3% in Q1 2026, buying an estimated $279K and bringing the position to 49,211 shares worth $9.64M. The position accounts for 0.73% of the portfolio, ranked #33.

Hilton Capital Management first reported a position in DGX in Q3 2024 and has held it in 7 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Hilton Capital Management held 49,211 shares of Quest Diagnostics worth $9.64M as of Q1 2026.
  • Hilton Capital Management bought 1,435 Quest Diagnostics shares in Q1 2026, an estimated $279K.
  • Quest Diagnostics made up 0.73% of Hilton Capital Management's portfolio in Q1 2026, its #33 holding.
  • Hilton Capital Management first reported a position in Quest Diagnostics in Q3 2024 and has held it in 7 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Hilton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.